ResMed (RMD)
(Delayed Data from NYSE)
$212.88 USD
-3.28 (-1.52%)
Updated May 8, 2024 04:00 PM ET
After-Market: $212.87 -0.01 (0.00%) 7:58 PM ET
1-Strong Buy of 5 1
D Value B Growth D Momentum C VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/01/2024
Time: -- |
6/2024 | $1.99 | 2.62% |
Earnings Summary
For their last quarter, ResMed (RMD) reported earnings of $2.13 per share, beating the Zacks Consensus Estimate of $1.92 per share. This reflects a positive earnings surprise of 10.94%. Look out for RMD's next earnings release expected on August 01, 2024. For the next earning release, we expect the company to report earnings of $1.99 per share, reflecting a year-over-year increase of 24.38%.
Earnings History
Price & Consensus
Zacks News for RMD
Myriad Genetics (MYGN) Posts Narrower-Than-Estimate Loss in Q1
RMD: What are Zacks experts saying now?
Zacks Private Portfolio Services